These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29101669)

  • 1. 25OH vitamin D levels in pediatric patients affected by Prader-Willi syndrome.
    Fintini D; Pedicelli S; Bocchini S; Bizzarri C; Grugni G; Cappa M; Crinò A
    J Endocrinol Invest; 2018 Jun; 41(6):739-742. PubMed ID: 29101669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentric Italian case-control study on 25OH vitamin D levels in children and adolescents with Prader-Willi syndrome.
    Panfili FM; Convertino A; Grugni G; Mazzitelli L; Bocchini S; Crinò A; Campana G; Cappa M; Delvecchio M; Faienza MF; Licenziati MR; Mariani M; Osimani S; Pajno R; Patti G; Rutigliano I; Sacco M; Scarano E; Fintini D;
    J Endocrinol Invest; 2023 Jul; 46(7):1397-1406. PubMed ID: 36708456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Sun's Vitamin in Adult Patients Affected by Prader-Willi Syndrome.
    Barrea L; Muscogiuri G; Pugliese G; Aprano S; de Alteriis G; Di Somma C; Colao A; Savastano S
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32316673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disorders of glucose metabolism in Prader-Willi syndrome: Results of a multicenter Italian cohort study.
    Fintini D; Grugni G; Bocchini S; Brufani C; Di Candia S; Corrias A; Delvecchio M; Salvatoni A; Ragusa L; Greggio N; Franzese A; Scarano E; Trifirò G; Mazzanti L; Chiumello G; Cappa M; Crinò A;
    Nutr Metab Cardiovasc Dis; 2016 Sep; 26(9):842-7. PubMed ID: 27381990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome.
    Crinò A; Di Giorgio G; Manco M; Grugni G; Maggioni A
    Horm Res; 2007; 68(2):83-90. PubMed ID: 17337902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetic background and vitamin D supplementation can affect irisin levels in Prader-Willi syndrome.
    Faienza MF; Brunetti G; Grugni G; Fintini D; Convertino A; Pignataro P; Crinò A; Colucci S; Grano M
    J Endocrinol Invest; 2021 Oct; 44(10):2261-2271. PubMed ID: 33656700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fat-Free Mass Is Better Related to Serum Uric Acid Than Metabolic Homeostasis in Prader-Willi Syndrome.
    Marzullo P; Mele C; Minocci A; Mai S; Scacchi M; Sartorio A; Aimaretti G; Grugni G
    Nutrients; 2020 Aug; 12(9):. PubMed ID: 32854398
    [No Abstract]   [Full Text] [Related]  

  • 8. High levels of LIGHT/TNFSF14 in patients with Prader-Willi syndrome.
    Faienza MF; Brunetti G; Fintini D; Grugni G; Wasniewska MG; Crinò A; D'Amato G; Piacente L; Oranger A; Dicarlo M; Colucci S; Grano M
    J Endocrinol Invest; 2023 Sep; 46(9):1901-1909. PubMed ID: 36917420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy.
    Festen DA; van Toorenenbergen A; Duivenvoorden HJ; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1549-54. PubMed ID: 17264186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of adiponectin receptor expression with cytokines and insulin sensitivity in growth hormone (GH)-treated children with Prader-Willi syndrome and in non-GH-treated obese children.
    Sohn YB; Kwak MJ; Kim SJ; Park SW; Kim CH; Kim MY; Kwon EK; Paik KH; Jin DK
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1371-7. PubMed ID: 20061428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of GH deficiency in Prader-Willi syndrome.
    Grugni G; Marzullo P
    Best Pract Res Clin Endocrinol Metab; 2016 Dec; 30(6):785-794. PubMed ID: 27974191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome.
    Haqq AM; Farooqi IS; O'Rahilly S; Stadler DD; Rosenfeld RG; Pratt KL; LaFranchi SH; Purnell JQ
    J Clin Endocrinol Metab; 2003 Jan; 88(1):174-8. PubMed ID: 12519848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body fat excess and stimulated growth hormone levels in adult patients with Prader-Willi syndrome.
    Grugni G; Crinò A; Bertocco P; Marzullo P
    Am J Med Genet A; 2009 Feb; 149A(4):726-31. PubMed ID: 19267411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GHRH + arginine stimulated pituitary GH secretion in children and adults with Prader-Willi syndrome shows age- and BMI-dependent and genotype-related differences.
    Marostica E; Grugni G; De Nicolao G; Marazzi N; Crinò A; Cappa M; Sartorio A
    Growth Horm IGF Res; 2013 Dec; 23(6):261-6. PubMed ID: 24090687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-like 8 (ANGPTL8) as a potential predictor of NAFLD in paediatric patients with Prader-Willi Syndrome.
    Mele C; Crinò A; Fintini D; Mai S; Convertino A; Bocchini S; Di Paolo P; Grugni G; Aimaretti G; Scacchi M; Marzullo P
    J Endocrinol Invest; 2021 Jul; 44(7):1447-1456. PubMed ID: 33067796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Alcoholic Fatty Liver Disease (NAFLD) in children and adolescents with Prader-Willi Syndrome (PWS).
    Fintini D; Inzaghi E; Colajacomo M; Bocchini S; Grugni G; Brufani C; Cappa M; Nobili V; Cianfarani S; Crinò A
    Pediatr Obes; 2016 Jun; 11(3):235-8. PubMed ID: 26132376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose growth hormone treatment in infants and toddlers with Prader-Willi syndrome is comparable to higher dosage regimens.
    Scheermeyer E; Harris M; Hughes I; Crock PA; Ambler G; Verge CF; Bergman P; Werther G; Craig ME; Choong CS; Davies PSW;
    Growth Horm IGF Res; 2017 Jun; 34():1-7. PubMed ID: 28427039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment.
    Bakker NE; Kuppens RJ; Siemensma EP; Tummers-de Lind van Wijngaarden RF; Festen DA; Bindels-de Heus GC; Bocca G; Haring DA; Hoorweg-Nijman JJ; Houdijk EC; Jira PE; Lunshof L; Odink RJ; Oostdijk W; Rotteveel J; Van Alfen AA; Van Leeuwen M; Van Wieringen H; Wegdam-den Boer ME; Zwaveling-Soonawala N; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1609-18. PubMed ID: 25668198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors for type 2 diabetes mellitus with Prader-Willi syndrome: a single center experience.
    Yang A; Kim J; Cho SY; Jin DK
    Orphanet J Rare Dis; 2017 Aug; 12(1):146. PubMed ID: 28854950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth Hormone Treatment for Adults With Prader-Willi Syndrome: A Meta-Analysis.
    Rosenberg AGW; Passone CGB; Pellikaan K; Damiani D; van der Lely AJ; Polak M; Bernardo WM; de Graaff LCG
    J Clin Endocrinol Metab; 2021 Sep; 106(10):3068-3091. PubMed ID: 34105729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.